Shilpa Medicare Ltd Share Price NSE India S.E.
Equities
INE790G01023
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- INR | - |
04-18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
04-17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
Sales 2022 | 11.47B 138M 10.85B | Sales 2023 | 10.52B 126M 9.95B | Capitalization | 19.91B 239M 18.83B |
---|---|---|---|---|---|
Net income 2022 | 607M 7.29M 574M | Net income 2023 | -325M -3.9M -307M | EV / Sales 2022 | 3.58 x |
Net Debt 2022 | 6.58B 79.02M 6.22B | Net Debt 2023 | 7.79B 93.57M 7.37B | EV / Sales 2023 | 2.63 x |
P/E ratio 2022 |
54.7
x | P/E ratio 2023 |
-61.3
x | Employees | - |
Yield 2022 |
0.28% | Yield 2023 |
-
| Free-Float | 39.28% |
Latest transcript on Shilpa Medicare Ltd
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 19/11/87 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 30/05/21 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 19/11/87 | |
Director/Board Member | 58 | 01/09/21 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 01/09/21 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |